| |
|
Medical Laboratories & Research News
|
Clarient Announces CFO Transition Plan
Wed 6:00 am ET (PR Newswire)
Clarient, Inc. , a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced a Chief Financial Officer transition plan that calls for veteran financial executive Michael R.
|
| Intraday
Price Performance | % Change | Market
Cap |
|
Top-Ranked Analysts
|
Provided by StarMine
|
| | |
Locate Industry by Company
|
| Market Capitalization: | 31B | | Price
/ Earnings: | 16.4 | | Price
/ Book: | -8.0 | | Net
Profit Margin (mrq): | 8.8% | | Price
To Free Cash Flow (mrq): | 59.1 | | Return
on Equity: | 14.4% | | Total
Debt / Equity: | 0.0 | | Dividend
Yield: | 0.7% |
|